Flash Grant Frequently Asked Questions

Return to the Flash Grant webpage.

  • What is the definition of “disruptive technology” for the Flash Grants?

    Disruptive technologies are those that dramatically or radically change products, markets, industries, or business models, such that a new market, process, product, or value is created, while at the same time, displacing, eliminating, or fundamentally altering an existing one. 

  • What is the definition of “translational research phase” of development for the Flash Grants?According to the NIH, translational research is “is the process of turning observations in the laboratory, clinic and community into interventions that improve the health of individuals and the public.”

    Basic scientific research is constructed to confirm hypotheses about underlying biological mechanisms based on observations of biological phenomenon.  By contrast, translational research projects are designed to explore and develop practical applications of this foundational knowledge, with the goal of creating solutions to significant societal needs.

  • Can you give some examples of Flash Grant projects?

    Examples of Flash Grant projects include:

    • Core facility fees or instrumentation usage fees
    • Proof-of-concept and feasibility studies for disruptive technologies/discoveries
    • Compound screening against a validated target; access to compound libraries
    • Prototype development
    • Scale-up pilot studies
    • Optimization studies
    • Algorithm development and validation
    • Precision feed ingredient studies
    • Plant-based products influenced by environmental growing conditions
    • Quality assurance of genetic or biostimulant agricultural measures
  • Can commercial/business development projects be funded with a Flash grant?
    Commercial/business development activities can be conducted as part of a Flash grant, but cannot be the sole activities proposed and undertaken with Flash grant funding. Commercial/business data to be gathered may include voice of customer outreach, IP landscaping, market and competitor data, reimbursement strategies, regulatory approval strategies, etc.

  • How do you define "precision health"?

    Precision health is a multi-disciplinary health care approach that utilizes knowledge about an individual’s genome, environment, lifestyle, and applicable technologic innovation to more precisely and efficiently predict risk, diagnose disease, target therapies, inform health care decisions, and personalize health and wellness plans.


    Precision Health combines data about an individual’s genes, environment, and lifestyle with innovation and drivers partnerships to more precisely predict and diagnose disease, target therapies, and personalize health and wellness plans.

  • How do you define "digital- and data-driven" technologies?
    Digital- and data-driven life science technologies are technologies that exist at the convergence of the life sciences with breakthrough electronic data collection/storage/analysis platforms. The Flash Grant may be used to fund the initial development or validation of such a platform that is novel and directly addresses an unmet, life science-related need.


    Data-driven life science technologies include but are not limited to:

    • FAIR Data Practices
      • Indexing
      • Metadata capture
      • Security, privacy, consenting, and IP protection
    • Computational Biology
      • Bioinformatics
      • Macromolecular structures
      • Genome sequences
      • Functional genetics
      • Macromolecular geometry
      • Phylogenetic tree construction
      • Protein structure/function
      • Gene finding
      • Expression data analysis
    • Biostatistics
      • Genome-wide association studies
      • Transcriptome-wide association studies
    • Data Science
      • Cloud computing
      • Machine learning (ML) and artificial intelligence (AI)
      • Lab automation